Search Results - "Steckler, Thomas"
-
1
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
Published in PLoS biology (14-07-2020)“…Reproducible science requires transparent reporting. The ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments) were originally developed in…”
Get full text
Journal Article -
2
Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0
Published in PLoS biology (14-07-2020)“…Improving the reproducibility of biomedical research is a major challenge. Transparent and accurate reporting is vital to this process; it allows readers to…”
Get full text
Journal Article -
3
Pharmacological treatment of PTSD – Established and new approaches
Published in Neuropharmacology (01-02-2012)“…A large proportion of humans will experience a traumatic event at least once in their lifetime, with up to 10% then going on to developing posttraumatic stress…”
Get full text
Journal Article -
4
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
Published in Journal of cerebral blood flow and metabolism (01-09-2020)“…Reproducible science requires transparent reporting. The ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments) were originally developed in…”
Get full text
Journal Article -
5
The ARRIVE guidelines 2.0: updated guidelines for reporting animal research
Published in The Journal of physiology (01-09-2020)“…Reproducible science requires transparent reporting. The ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments) were originally developed in…”
Get full text
Journal Article -
6
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
Published in Experimental physiology (01-09-2020)“…Reproducible science requires transparent reporting. The ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments) were originally developed in…”
Get full text
Journal Article -
7
Negative symptoms of schizophrenia: Clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment
Published in European neuropsychopharmacology (01-05-2014)“…Abstract Schizophrenia is a complex and multifactorial disorder generally diagnosed in young adults at the time of the first psychotic episode of delusions and…”
Get full text
Journal Article -
8
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
Published in BMC veterinary research (14-07-2020)“…Reproducible science requires transparent reporting. The ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments) were originally developed in…”
Get full text
Journal Article -
9
NMDA receptors, cognition and schizophrenia – Testing the validity of the NMDA receptor hypofunction hypothesis
Published in Neuropharmacology (01-03-2012)“…Cognitive dysfunction is core to schizophrenia, and remains poorly treated by existing therapies. A prominent hypothesis suggests that many symptoms arise from…”
Get full text
Journal Article -
10
Metabolomic biosignature differentiates melancholic depressive patients from healthy controls
Published in BMC genomics (23-08-2016)“…Major depressive disorder (MDD) is a heterogeneous disease at the level of clinical symptoms, and this heterogeneity is likely reflected at the level of…”
Get full text
Journal Article -
11
Nicotine Improves Working Memory Span Capacity in Rats Following Sub-Chronic Ketamine Exposure
Published in Neuropsychopharmacology (01-12-2011)“…Ketamine, an NMDA-receptor antagonist, produces cognitive deficits in humans in a battery of tasks involving attention and memory. Nicotine can enhance various…”
Get full text
Journal Article -
12
PEERS - An Open Science "Platform for the Exchange of Experimental Research Standards" in Biomedicine
Published in Frontiers in behavioral neuroscience (21-10-2021)“…Laboratory workflows and preclinical models have become increasingly diverse and complex. Confronted with the dilemma of a multitude of information with…”
Get full text
Journal Article -
13
Corticotropin-releasing hormone receptor subtypes and emotion
Published in Biological psychiatry (1969) (01-12-1999)“…Preclinical data indicate that corticotropin-releasing hormone (CRH) has anxiogenic properties and a dysregulation in CRH systems has been suggested to play a…”
Get full text
Journal Article -
14
The preclinical data forum network: A new ECNP initiative to improve data quality and robustness for (preclinical) neuroscience
Published in European neuropsychopharmacology (01-10-2015)“…Abstract Current limitations impeding on data reproducibility are often poor statistical design, underpowered studies, lack of robust data, lack of…”
Get full text
Journal Article -
15
In vivo electroporation of the central nervous system: a non-viral approach for targeted gene delivery
Published in Progress in neurobiology (01-11-2010)“…Electroporation is a widely used technique for enhancing the efficiency of DNA delivery into cells. Application of electric pulses after local injection of DNA…”
Get full text
Journal Article -
16
Blocking melanin-concentrating hormone MCH1 receptor affects rat sleep-wake architecture
Published in European journal of pharmacology (28-01-2008)“…Melanin-concentrating hormone (MCH) is a hypothalamic peptide that centrally regulates food intake, energy balance and emotion. Interestingly, MCH and…”
Get full text
Journal Article -
17
Metabotropic glutamate mGlu1 receptor stimulation and blockade: Therapeutic opportunities in psychiatric illness
Published in European journal of pharmacology (01-08-2010)Get full text
Journal Article -
18
Modulation of group II metabotropic glutamate receptor (mGlu 2) elicits common changes in rat and mice sleep–wake architecture
Published in European journal of pharmacology (28-01-2009)“…Compiling pharmacological evidence implicates metabotropic glutamate mGlu 2 receptors in the regulation of emotional states and suggests positive modulators as…”
Get full text
Journal Article -
19
Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1
Published in Nature genetics (01-06-1998)“…Corticotropin-releasing hormone (CRH) is a potent mediator of endocrine, autonomic, behavioural and immune responses to stress, and has been implicated in the…”
Get full text
Journal Article -
20
IMPA1 is essential for embryonic development and lithium-like pilocarpine sensitivity
Published in Neuropsychopharmacology (New York, N.Y.) (01-02-2008)“…Lithium has been the standard pharmacological treatment for bipolar disorder over the last 50 years; however, the molecular targets through which lithium…”
Get full text
Journal Article